Status:
COMPLETED
A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine
Lead Sponsor:
George Washington University
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Investigators in the Division of Infectious Diseases and the Division of Hospital Medicine of The George Washington University Medical Center are carrying out a study to determine if hospitalized pati...
Eligibility Criteria
Inclusion
- Males or female patients ages 18 or older
- Diagnosis of pneumonia requiring hospitalization
- Admission to the Medicine Ward under the Pneumonia Core Measure protocol
- Eligible to receive standard of care pneumococcal vaccine by the treating physician
- Able to receive an injection
- Able to provide informed consent
Exclusion
- Preexisting history of immunosuppression, to include any of the following: HIV/AIDS, Chronic corticosteroid use, Malignancy requiring myeloablative chemotherapy, Hematologic malignancy, History of solid organ or stem cell transplant
- Pregnancy
- Receipt of pneumococcal vaccine within the last 5 years
- Prior history of hypersensitivity reaction to the vaccine
- Unable to return for follow-up testing
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00955851
Start Date
June 1 2009
End Date
July 1 2010
Last Update
July 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University Hospital
Washington D.C., District of Columbia, United States, 20037